|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/569 | (2006.01) |
| A61K 39/00 | (2006.01) | ||
| C12Q 1/68 | (2018.01) | ||
| G01N 33/68 | (2006.01) |
| (11) | Number of the document | 3194970 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15772084.8 |
| Date of filing the European patent application | 2015-09-10 | |
| (97) | Date of publication of the European application | 2017-07-26 |
| (45) | Date of publication and mention of the grant of the patent | 2021-07-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/049491 |
| Date | 2015-09-10 |
| (87) | Number | WO 2016/040682 |
| Date | 2016-03-17 |
| (30) | Number | Date | Country code |
| 201462048742 P | 2014-09-10 | US |
| (72) |
DELAMARRE, Lelia , US
LUPARDUS, Patrick , US
MELLMAN, Ira , US
YADAV, Mahesh , US
JHUNJHUNWALA, Suchit , US
LILL, Jennie , US
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | IMMUNOGENIC MUTANT PEPTIDE SCREENING PLATFORM |
| IMMUNOGENIC MUTANT PEPTIDE SCREENING PLATFORM |